1. Svend A. Mortensen et al. JCHF 2014;2:641-649
Kaplan-Meier Estimates of the Time to Primary and Secondary Endpoints Kaplan-Meier estimates of the time to the primary endpoint major adverse cardiovascular events (MACE) (A) and the secondary outcome death (B) in the placebo group (solid line) and the coenzyme Q10 (CoQ10) group (dashed line). The primary endpoint was composite MACE of hospital stay for worsening heart failure, cardiovascular death, mechanical support, or urgent cardiac transplantation. A specified secondary outcome was death from any cause. CI = confidence interval; HR = hazard ratio.
Svend A. Mortensen et al. JCHF 2014;2:
American College of Cardiology Foundation